TRAP-1 Use of TRAP-1 inhibitor for treating eye diseases

The present specification provides a use of a compound that inhibits TRAP1 or a pharmaceutically acceptable salt thereof for the treatment of ophthalmic diseases. Specifically, the present specification provides a composition for treating ophthalmic diseases comprising a compound that inhibits TRAP1...

Full description

Saved in:
Bibliographic Details
Main Authors KANG BYOUNG HEON, YOON NAM GU, KIM SO YEON
Format Patent
LanguageEnglish
Korean
Published 22.12.2022
Subjects
ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAININGELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN,SULFUR, SELENIUM OR TELLURIUM
CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The present specification provides a use of a compound that inhibits TRAP1 or a pharmaceutically acceptable salt thereof for the treatment of ophthalmic diseases. Specifically, the present specification provides a composition for treating ophthalmic diseases comprising a compound that inhibits TRAP1 or a pharmaceutically acceptable salt thereof, and uses thereof. 본 명세서는 TRAP1을 억제하는 화합물 또는 이의 약학적으로 허용가능한 염의 안과질환 치료 용도를 제공한다. 구체적으로, 본 명세서는 TRAP1을 억제하는 화합물 또는 이의 약학적으로 허용가능한 염을 포함하는 안과질환 치료용 조성물 및 이의 용도를 제공한다.
Bibliography:Application Number: KR20210077326